CA SB 524 Comment Letter (2021)
PCMA delivers a comment letter to the chair of the Assembly committee on Business and Professions addressing steering and mail order proposed provisions.
OK Coalition Comment Letter to BoP (2023)
Coalition letter in opposition to a Board of Pharmacy proposed rule that would require temperature controlled packaging for all drug delivery, regardless of specific temperature
MA Bundle of Bills Testimony (2021)
PCMA submits testimny to the Joint Committee on Financial Services regarding a bucket list of bills addressing a wide range of PBM regulations.
CA SB 524 Comment Letter
PCMA delivers a comment letter to the sponsor of SB 602, a bill that aims to prohibit PBMs ability to steer patients to lower cost,
CA SB 524 Comment Letter
PCMA provides comment letter to the CA Senate Health Committee opposing SB 524, an anti-steering bill. If enacted, the bill would prohibit PBMs from offering
PCMA Comment Letter OR HB 485 (2019)
This letter was submitted by PCMA regarding OR HB485 dealing with mail order pharmacies and clarification on the pharmacy appeal process.
PCMA GA HB233 Veto Request Letter (2019)
This veto request letter was submitted by PCMA in regards to GA HB233, an anti-steering bill.
PCMA Comment Letter MA Joint Healthcare Finance Committee (2019)
This comment letter was submitted to the MA Joint Health Care Finance Committee regarding multiple PBM related pieces of legislation.
PCMA MT SB71 Veto Request Letter (2019)
This veto request letter was submitted by PCMA in regards to MT SB 71 which would require a single formulary and prevent mail order pharmacies
CO Drug Supply Chain Comment Letter (2019)
This comment letter submitted by PCMA outlines the PBM value proposition and highlights tools used by PBMs to restrain increasing prescription drug costs.
PCMA AR Comment Letter (2018)
This comment letter from PCMA that was sent to every Arkansas legislator provides a comprehensive overview of the value that PBMs provide to their clients,
ND – Comment Letter: Proposed Pharmacy Board Rules 61-04-12 and 61-08-01-10 regarding patient counseling services and their impact on mail order pharmacies (May 2016)
PCMA comment letter regarding the proposed changes to Rule 61-04-12 regarding patient consultation requirements and 61-08-01-10 regarding patient counseling services.
PCMA member companies are concerned that the proposed regulations unfairly hinder out-of-state mail order pharmacy practice. For no clear reason, section 61-04-12(3) establishes a separate standard to “provide counseling” to patients who are “required by their insurance plan to use or [are] financially incentivized to use a pharmacy which provides mail-order prescription service.” There is no explanation of the difference between providing “consultation” and providing “counseling” in these circumstances, or what warrants a separate section for patients whose plans provide a financial incentive to use a lower-cost alternative delivery system.